DAVPX
Price
$39.82
Change
-$0.08 (-0.20%)
Updated
Jul 13 closing price
Net Assets
1.29B
VTSAX
Price
$179.98
Change
-$1.44 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

DAVPX vs VTSAX

DAVPX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
DAVPX vs. VTSAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAVPX is a Buy and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.3T vs. DAVPX (1.29B). VTSAX pays higher dividends than DAVPX: VTSAX (1.04) vs DAVPX (0.03). DAVPX was incepted earlier than VTSAX: DAVPX (29 years) vs VTSAX (26 years). DAVPX (0.85) is less costly to investors than VTSAX (0.04). DAVPX is a more actively managed with annual turnover of: 16.00 vs. VTSAX (3.00). VTSAX has a lower initial minimum investment than DAVPX: VTSAX (3000) vs DAVPX (5000). VTSAX annual gain was more profitable for investors over the last year : 21.47 vs. DAVPX (5.47). VTSAX return over 5 years is better than : 66.46 vs. DAVPX (20.92).
DAVPXVTSAXDAVPX / VTSAX
Total Expense Ratio0.850.042,125%
Annual Report Gross Expense Ratio0.850.042,125%
Fund Existence29 years26 years-
Gain YTD4.39811.20739%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets1.29B2.3T0%
Annual Yield % from dividends0.031.043%
Returns for 1 year5.4721.4725%
Returns for 3 years35.6067.0053%
Returns for 5 years20.9266.4631%
Returns for 10 years111.75250.4845%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEMVX18.58N/A
N/A
Causeway Emerging Markets Investor
GSMYX25.93N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
VGSIX32.36N/A
N/A
Vanguard Real Estate Index Investor
TBWCX21.92N/A
N/A
Thornburg Better World International C
MCYVX16.17-0.50
-3.00%
NYLI Candriam Emerging Markets Eq Inv Cl